SKYE vs. SGMT, CRVO, RPTX, CTMX, SYRS, PRQR, OPTN, RAPT, CYBN, and INCR
Should you be buying Skye Bioscience stock or one of its competitors? The main competitors of Skye Bioscience include Sagimet Biosciences (SGMT), CervoMed (CRVO), Repare Therapeutics (RPTX), CytomX Therapeutics (CTMX), Syros Pharmaceuticals (SYRS), ProQR Therapeutics (PRQR), OptiNose (OPTN), RAPT Therapeutics (RAPT), Cybin (CYBN), and InterCure (INCR). These companies are all part of the "pharmaceutical preparations" industry.
Skye Bioscience (NASDAQ:SKYE) and Sagimet Biosciences (NASDAQ:SGMT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.
Sagimet Biosciences' return on equity of -61.85% beat Skye Bioscience's return on equity.
Sagimet Biosciences received 13 more outperform votes than Skye Bioscience when rated by MarketBeat users.
21.1% of Skye Bioscience shares are held by institutional investors. Comparatively, 87.9% of Sagimet Biosciences shares are held by institutional investors. 0.7% of Skye Bioscience shares are held by company insiders. Comparatively, 17.6% of Sagimet Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Skye Bioscience presently has a consensus target price of $22.50, suggesting a potential upside of 87.50%. Sagimet Biosciences has a consensus target price of $38.80, suggesting a potential upside of 688.62%. Given Sagimet Biosciences' higher possible upside, analysts clearly believe Sagimet Biosciences is more favorable than Skye Bioscience.
Sagimet Biosciences has higher revenue and earnings than Skye Bioscience.
In the previous week, Sagimet Biosciences had 16 more articles in the media than Skye Bioscience. MarketBeat recorded 18 mentions for Sagimet Biosciences and 2 mentions for Skye Bioscience. Sagimet Biosciences' average media sentiment score of 0.54 beat Skye Bioscience's score of -0.99 indicating that Sagimet Biosciences is being referred to more favorably in the news media.
Summary
Sagimet Biosciences beats Skye Bioscience on 11 of the 11 factors compared between the two stocks.
Get Skye Bioscience News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKYE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SKYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skye Bioscience Competitors List
Related Companies and Tools
